RTW Venture Fund Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported revenue was USD 0.698746 million compared to USD 0.145233 million a year ago. Net loss was USD 103.86 million compared to USD 18.14 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +0.38% | +1.53% | -5.53% |
Apr. 05 | RTW Biotech invests in cell and gene therapy company Obsidian | AN |
Apr. 02 | EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises | AN |
1st Jan change | Capi. | |
---|---|---|
-5.53% | 510M | |
+3.00% | 12.52B | |
+7.33% | 8.84B | |
-3.71% | 5.39B | |
+5.13% | 5.16B | |
-0.21% | 5.11B | |
+14.85% | 4.51B | |
+16.63% | 4.44B | |
+1.69% | 4.01B | |
+1.09% | 3.75B |
- Stock Market
- Equities
- RTWG Stock
- News RTW Biotech Opportunities Ltd
- RTW Venture Fund Limited Reports Earnings Results for the Half Year Ended June 30, 2022